One-Year Treatment Outcomes of Ziv-Aflibercept for Treatment-Naïve Macular Oedema in Branch Retinal Vein Occlusion

Acta Ophthalmologica - United States
doi 10.1111/aos.13432
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Intravitreal Bevacizumab for the Treatment of Macular Oedema Secondary to Branch Retinal Vein Occlusion

British Journal of Ophthalmology
Molecular NeuroscienceOphthalmologySensory SystemsCellular
2008English

Treatment Outcomes of Ziv-Aflibercept for Treatment-Naïve Polypoidal Choroidal Vasculopathy

Acta Ophthalmologica
MedicineOphthalmology
2017English

Intravitreal Triamcinolone Acetonide vs Bevacizumab for Treatment of Macular Oedema Secondary to Branch Retinal Vein Occlusion

Eye
MedicineArtsSensory SystemsOphthalmologyHumanities
2009English

Intravitreal PRN Ranibizumab Treatment for Macular Edemadue to Branch Retinal Vein Occlusion

Turkish Journal of Medical Sciences
Medicine
2017English

Macular Cystic Changes as Predictive Factor for the Recurrence of Macular Oedema in Branch Retinal Vein Occlusion

Acta Ophthalmologica
MedicineOphthalmology
2017English

Intravitreal Bevacizumab for Macular Oedema Secondary to Branch Retinal Vein Occlusion: More Data Required

Eye
MedicineArtsSensory SystemsOphthalmologyHumanities
2009English

Comparison Between the Short-Term Outcomes of Bevacizumab and Ziv-Aflibercept in the Treatment of Primary Diabetic Macular Oedema

Acta Ophthalmologica
MedicineOphthalmology
2017English

Relationship Between Perifoveal Capillaries and Pathomorphology in Macular Oedema Associated With Branch Retinal Vein Occlusion

Eye
MedicineArtsSensory SystemsOphthalmologyHumanities
2012English

A Meta-Analysis of Patients With Treatment-Resistant Macular Oedema Secondary to Retinal Vein Occlusions Following Switching to Aflibercept

Acta Ophthalmologica
MedicineOphthalmology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy